The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma

Anti-Cancer Drugs

Volumn 7, Issue 4, 1996, Pages 493-498

  Mohith, Anil ^a   Photiou, Andrew ^a   Retsas, Spyros ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Antagonism; Cisplatin; Cytotoxicity; Isobologram,; Melanoma; Paclitaxel

Indexed keywords

CISPLATIN; DYE; PACLITAXEL; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MELANOMA; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0029949836     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199606000-00016     Document Type: Article

References (20)

1. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Pennsylvania: Lippincott 1993: 1636-7.
2. Retsas S, Bayliss M, Sheikh N, Chong SL, et al. Chemotherapy of malignant melanoma: the European experience. Revue Med Interne 1990; 11: 51-8.
3. Retsas S. Strategies for improving survival in malignant melanoma: focus on vindesine. J Drug Dev Clin Pract 1995; 7: 159-71.
4. Legha SS, Ring S, Papadopoulos N, et al. Phase II trial of taxol in malignant melanoma. Cancer 1990; 65: 2478-81.
5. Einzig AI, Wierknik PH, Melanoma. In: McGuire WP, Rowinsky EK, eds. Paclitaxel in cancer treatment New York: Marcel Dekker 1995: 321-7.
6. Ozols RF. Carboplatin and paclitaxel in ovarian cancer. Semin Oncol 1995; 22: 78-83.
7. Ettinger DS, Finkelstein DM, Sarma RP, et al. Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 1995; 13: 1430-5.
8. Rowinsky EK, Citardi MJ, Noe AD, et al. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine. J Cancer Res Clin Oncol 1993; 119: 727-33.
9. Jekunen AP, Christen RD, Shalinsky DR, et al. Synergistic interaction between cisplatin and paclitaxel in human ovarian carcinoma cells in vitro. Br J Cancer 1994; 69: 299-306.
10. Vanhoefer U, Harstrick A, Wilke H, et al Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro. Eur J Cancer 1995; 31: 92-7.
11. Chou TC, Motzer J, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism of Taxol, Topotecan, and Cisplatin against human teratocarcinoma cell growth: a rationale approach to clinical protocol design. J Natl Cancer Inst 1994; 86: 1517-24.
12. Photiou A, Sheikh MN, Bafaloukos D, Retsas S Anti-proliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. J Cancer Res Clin Oncol 1992; 118: 249-54.
13. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 1990; 13: 1107-18.
14. Rowinsky EK, Gilbert MR, McGuire WP, et al. Sequences of Taxol and Cisplatin: a phase II and pharmacologic study. J Clin Oncol 1991; 9: 1692-703.
15. Mohammed MQ, Photiou A, Shah P, Retsas S. Activity of platinum drugs against melanoma cell lines: is it modulated in vitro in the presence of tamoxifen. Anti-Cancer Res 1995; 15: 1319-26.
16. Berenbaum MC. What is synergy? Pharmacol Rev 1989; 41: 93- 140.
17. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol 1979; 5: 85-91.
18. Okano T, Ohnuma T, Holland JF, et al. Effects of harringtonine in combination with acivin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous cell line KG-1. Invest New Drugs 1983; 1: 145-50.
19. Rixe O, Alvarez M, Mickley L, et al. Cisplatin resistance is multifactorial and includes changes in cytoskeletal distrihution and dynamics. Proc Am Ass Cancer Res 1993; 34: 406.
20. Peyroth V, Briand C, Crevat A. Action of hydrolysed cisplatin and some analogues on microtubule protein polymerization in vitro. Cancer Treat Rep 1983; 67: 641-6.